Enhancement of mitochondrial function fosters B cell immune memory
Shukla, A.; Tiwari, A.; Saulnier, O.; Hendrikse, L. D.; Hall, B.; Rickert, R.; Taylor, M.; Shukla, V.; Bagchi, A.
Show abstract
Differentiation of T and B cells to effector and memory cell fates are associated with extensive metabolic changes which are accompanied by altered mitochondrial dynamics. However, whether alterations in mitochondrial structure and function plays an active role in regulating effector versus memory cell fate decisions during immune responses remains unclear. Our studies here characterize changes in mitochondrial dynamics in activated B cells and show that increased mitochondrial mass and activity is a distinct feature of memory B cell lineage commitment in vivo. Using a directed screen of mitochondrial modulators, we identify mitochondrial fission inhibitor, Mdivi-1 as an agent that could enhance mitochondrial mass and function leading to augmented memory B cell differentiation. The enhanced memory B cell responses mediated by Mdivi-1, translated to more robust recall responses upon secondary antigen exposures. Moreover, Mdivi-1 when used in combination with subunit (SARS-CoV2) and inactivated (H1N1 influenza) vaccines led to remarkably improved vaccine efficacies and protection from lethal viral (H1N1) challenge. Single-cell transcriptomics revealed enhanced commitment to memory lineage differentiation in B cells following Mdivi-1 treatment. We propose that mitochondrial modulators such as Mdivi-1 are a novel class of "immune enhancers" that specifically reinforces immunological memory and could be broadly applied to improve the fidelity of immune responses and vaccine efficacies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An intranasal vaccine durably protects against SARS-CoV-2 variants in mice 96%
- Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy 95%
- Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters 95%
Similar papers in this journal
- Metformin enhances anti-mycobacterial responses by educating immunometabolic circuits of CD8+ T cells 96%
- CD8 + T-cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph 96%
- T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling 96%
Similar papers in this journal
- Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2 96%
- Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques 96%
- Genetic immune response and antibody repertoire of heterologous ChAdOx1-BNT162b2 vaccination in a Korean cohort 95%
Similar papers in this journal
Similar papers in this journal
- Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity 96%
- MDSC depletion during immunization with heat-killed Mycobacterium tuberculosis increases protection against BCG infection. 95%
- Longitudinal cellular and humoral immune responses following Covid-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar. 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.